Suppr超能文献

益生菌作为生物药物的研发。

Development of probiotics as biologic drugs.

作者信息

Hoffman Freddie Ann

机构信息

HeteroGeneity, Washington, DC 20011, USA.

出版信息

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S125-7; discussion S144-51. doi: 10.1086/523326.

Abstract

In the United States, probiotics that are intended to be used to diagnose, cure, mitigate, treat, or prevent disease in humans or other animals and that affect the structure or the function of the body are considered to be drugs. This article provides a brief overview of the historical basis of US regulation of drugs and biologics and explores the legal, regulatory, and policy considerations for probiotics as biologic drugs for humans.

摘要

在美国,旨在用于诊断、治愈、减轻、治疗或预防人类或其他动物疾病且影响身体结构或功能的益生菌被视为药物。本文简要概述了美国药品和生物制品监管的历史依据,并探讨了将益生菌作为人类生物药物的法律、监管和政策考量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验